Relation between non-alcoholic fatty liver disease and carotid artery intimal media thickness as a surrogate for atherosclerosis: a systematic review and meta-analysis

被引:0
作者
Abosheaishaa, Hazem [1 ]
Nassar, Mahmoud [2 ]
Abdelhalim, Omar [1 ,10 ]
Bahbah, Ammar Ayman [3 ]
Abbas, Sharif [4 ]
Morsi, Samah M. [5 ]
Ghallab, Muhammad [1 ]
Alagha, Zakaria [6 ]
Omran, Ahmed [7 ]
Elfert, Khaled [8 ]
Bandaru, Praneeth [9 ]
Forlemu, Arnold Nongmoh [9 ]
Reddy, Madhavi [1 ]
机构
[1] NYC Hlth Hosp Queens, Icahn Sch Med Mt Sinai, Dept Internal Med, New York, NY USA
[2] Univ Buffalo, Sch Med & Biomed Sci, Buffalo, NY USA
[3] Menoufia Univ, Fac Med, Shibin Al Kawm, Egypt
[4] Koc Univ, Sch Med, Istanbul, Turkiye
[5] Duke Univ, Johns Hopkins Sch Med, Dept Radiol, Durham, NC USA
[6] Marshall Univ, Joan Edward Sch Med, Huntington, WV USA
[7] Trinitas Reg Med Ctr RWJBH, Lindon, UT USA
[8] St Barnabas Hlth Care Syst, New York, NY USA
[9] Brooklyn Hosp Ctr, Gastroenterol & Hepatol, Brooklyn, NY USA
[10] 70-42 Kissena Blvd, Queens, NY 11355 USA
关键词
atherosclerosis; CA-IMT; NAFLD; NASH; CARDIOVASCULAR RISK; METABOLIC SYNDROME; SUBCLINICAL ATHEROSCLEROSIS; ENDOTHELIAL DYSFUNCTION; VASCULAR DAMAGE; WALL THICKNESS; ASSOCIATION; POPULATION; STIFFNESS; HISTOLOGY;
D O I
10.1097/MEG.0000000000002721
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and objective Non-alcoholic fatty liver disease (NAFLD), characterized by hepatic steatosis without heavy alcohol consumption or other chronic conditions, encompasses a spectrum from non-alcoholic fatty liver to non-alcoholic steatohepatitis leading to cirrhosis. This analysis aimed to investigate the correlation between NAFLD and carotid intimal media thickness (C-IMT), a non-invasive surrogate for atherosclerosis. Methodology Database searches, including PubMed, EMBASE and Cochrane Library, yielded studies up to April 2023. Included were studies exploring the NAFLD-C-IMT relationship in populations aged >18 years. Exclusions comprised non-English papers, those involving animals or pediatric populations and studies lacking control groups. Results No statistical significance was noted between mild and moderate NAFLD compared to the control group regarding C-IMT [95% confidence intervals (CI): -0.03, 0.12] and (95% CI: -0.03, 0.21), respectively. There was a statistically significant difference only in the Severe NAFLD group (P value 0.03). NAFLD with and without metabolic syndrome showed statistically significant differences compared to control regarding C-IMT (95% CI: 0.04, 0.12) and (95% CI: 0.01, 0.07), respectively. Fifty-nine studies were mentioned without classification of NAFLD severity and revealed a high statistically significant difference between NAFLD and controls regarding C-IMT with (95% CI: 0.09, 0.12, P < 0.00001). Stratified analysis according to sex was done in two studies and revealed statistical differences between NAFLD and control regarding C-IMT in both groups. Conclusion This meta-analysis underscores a significant association between NAFLD and increased C-IMT, emphasizing the importance of assessing C-IMT in NAFLD patients to identify cardiovascular risk and tailor therapeutic interventions for improved patient outcomes.
引用
收藏
页码:592 / 607
页数:16
相关论文
共 50 条
[21]   Exercise and non-alcoholic fatty liver disease: A systematic review and meta-analysis [J].
Keating, Shelley E. ;
Hackett, Daniel A. ;
George, Jacob ;
Johnson, Nathan A. .
JOURNAL OF HEPATOLOGY, 2012, 57 (01) :157-166
[22]   Gastrointestinal cancers in lean individuals with non-alcoholic fatty liver disease: A systematic review and meta-analysis [J].
Souza, Matheus ;
Diaz, Ivanna ;
Barchetta, Ilaria ;
Mantovani, Alessandro .
LIVER INTERNATIONAL, 2024, 44 (01) :6-14
[23]   Prevalence of non-alcoholic fatty liver disease in postmenopausal woman: systematic review and meta-analysis [J].
Xiao, Xiong ;
Liu, Yang ;
Wei, Yan ;
He, Li .
CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY, 2021, 48 (01) :24-30
[24]   Non-alcoholic fatty liver disease as a risk factor for cholangiocarcinoma: a systematic review and meta-analysis [J].
Nicha Wongjarupong ;
Buravej Assavapongpaiboon ;
Paweena Susantitaphong ;
Wisit Cheungpasitporn ;
Sombat Treeprasertsuk ;
Rungsun Rerknimitr ;
Roongruedee Chaiteerakij .
BMC Gastroenterology, 17
[25]   Non-alcoholic fatty liver disease prevalence in Latin America: A systematic review and meta-analysis [J].
Rojas, Yesmi A. Ortega ;
Cuellar, Claudia L. Vidal ;
Barron, Karina M. Aparicio ;
Arab, Juan Pablo ;
Miranda, Adelina Lozano .
ANNALS OF HEPATOLOGY, 2022, 27 (06)
[26]   Effects and Safety of Sitagliptin in Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis [J].
Zhang, Yuhan ;
Cai, Tian ;
Zhao, Junyu ;
Guo, Congcong ;
Yao, Jinming ;
Gao, Peng ;
Dong, Jianjun ;
Liao, Lin .
HORMONE AND METABOLIC RESEARCH, 2020, 52 (07) :517-526
[27]   Hepatocellular and extrahepatic cancers in non-alcoholic fatty liver disease: A systematic review and meta-analysis [J].
Thomas, James A. ;
Kendall, Bradley J. ;
Dalais, Christine ;
Macdonald, Graeme A. ;
Thrift, Aaron P. .
EUROPEAN JOURNAL OF CANCER, 2022, 173 :250-262
[28]   Coffee Consumption and Non-alcoholic Fatty Liver Disease: An Umbrella Review and a Systematic Review and Meta-analysis [J].
Kositamongkol, Chayanis ;
Kanchanasurakit, Sukrit ;
Auttamalang, Chiraphong ;
Inchai, Nutkamon ;
Kabkaew, Thanatchaporn ;
Kitpark, Sarunporn ;
Chaiyakunapruk, Nathorn ;
Duangjai, Acharaporn ;
Saokaew, Surasak ;
Phisalprapa, Pochamana .
FRONTIERS IN PHARMACOLOGY, 2021, 12
[29]   The Visceral Adiposity Index in Non-Alcoholic Fatty Liver Disease and Liver Fibrosis-Systematic Review and Meta-Analysis [J].
Ismaiel, Abdulrahman ;
Jaaouani, Ayman ;
Leucuta, Daniel-Corneliu ;
Popa, Stefan-Lucian ;
Dumitrascu, Dan L. .
BIOMEDICINES, 2021, 9 (12)
[30]   Non-obese non-alcoholic fatty liver disease and the risk of chronic kidney disease: a systematic review and meta-analysis [J].
You, Yixian ;
Pei, Xiong ;
Jiang, Wei ;
Zeng, Qingmin ;
Bai, Lang ;
Zhou, Taoyou ;
Lv, Xiaoju ;
Tang, Hong ;
Wu, Dongbo .
PEERJ, 2024, 12